T-cell inflammation is prognostic of survival in patients with high-risk neuroblastoma enriched for an adrenergic signature.

Maria E Kaufman,Omar R Vayani,Kelley Moore,Alexandre Chlenski,Tong Wu,Gepoliano Chavez,Sang Mee Lee,Ami V Desai,Chuan He,Susan L Cohn,Mark A Applebaum

bioRxiv : the preprint server for biology（2023）

引用 1|浏览1

暂无评分

摘要

High inflammation scores were correlated with improved survival in some high-risk patients with, ADRN but not MES neuroblastoma. These findings have implications for approaches to treating high-risk neuroblastoma.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要